
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 340 - STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
##### Subpart C - Labeling
###### ยง 340.50 Labeling of stimulant drug products.
####### Indications.

(b)The labeling of the product states, under the heading "Indications," the following: "Helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness." Other truthful and nonmisleading statements, describing only the indications for use that have been established and listed in this paragraph (b), may also be used, as provided in ยง 330.1(c)(2), subject to the provisions of section 502 of the Act relating to misbranding and the prohibition in section 301(d) of the Act against the introduction or delivery for introduction into interstate commerce of unapproved new drugs in violation of section 505(a) of the Act.
